qPCR Guru, a free browser-based platform, strengthens microRNA analyses using full-curve Cq estimation

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Quantitative PCR (qPCR) depends on reliable quantification cycle (Cq) estimation from amplification curves, which are not always well-behaved. We developed qPCR Guru to provide a complete analysis pipeline including data quality assessment, relative quantification, standard-curve diagnostics, and dual-method Cq evaluation. The latter compares the conventional instrument-derived threshold (“Reported”) Cq versus the full-curve five-parameter logistic (5PL) second-derivative-maximum (“Fit”) Cq and automatically flags curve-shape abnormalities and disagreement between the two estimates. On high-expressing targets (mRNA and microRNA), the two methods showed strong convergence, confirming general-purpose performance. On low-expressing targets, such as serum microRNA, baseline artifacts and biphasic amplification result in threshold miscalls that standard instrument analysis does not flag. Fit Cq restored replicate-concordant values where Reported Cq split the technical replicates by 17–20 cycles, recovered MIQE-compliant amplification efficiencies lost to biphasic miscalls (from 74% to 102% and 387% to 98%), and lowered within-group variability by 48% and 68% in feline and bovine samples, respectively. Together, these results demonstrate that full-curve estimation, with integrated curve-level diagnostics, strengthens qPCR analyses against threshold miscalls.

ARTICLE HIGHLIGHTS

  • qPCR Guru is a free, browser-based platform that provides a complete analysis pipeline and facilitates side-by-side comparisons of an instrument’s threshold (Reported) Cq and a full-curve (Fit) Cq, from the five-parameter logistic fitting with second-derivative-maximum (SDM/cpD2).

  • For every well the application automatically flags curve-shape abnormalities and disagreement between the two Cq estimates.

  • On clean, high-expressing mRNA and microRNA targets, the two estimators (Reported Cq and Fit Cq) were strongly concordant and produced equivalent relative quantification with comparable precision.

  • In low-expressing serum microRNA, baseline artifacts and biphasic amplification produced threshold Cq miscalls of up to ∼20 cycles and were detected by curve-shape flags and/or method disagreement.

  • The full-curve Cq estimate recovered replicate-concordant values, restored MIQE-compliant amplification efficiencies, and reduced within-group variability in serum microRNA.

Article activity feed